跳至主要内容
临床试验/NCT06071208
NCT06071208尚未招募不适用

The National Plan To Prevent Diabetic Kidney Disease Among Egyptians: A Prospective Multicenter Randomized Controlled Study

Fayoum University0 个研究点目标入组 10,000 人开始时间: 2023年10月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
10,000
主要终点
prevention of diabetic complications

研究概览

简要总结

Study of the possibility to prevent the development of Diabetic kidney disease in type 2 diabetic patients

详细描述

Study of the possible role of the SGLT2 inhibitors to prevent the development of frank type2 DM among prediabetic candidates.

Study of the possible role of the SGLT2 inhibitors to prevent the development of diabetic complications, namely diabetic kidney disease, diabetic retinopathy and neuropathy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diabetics,prediabetics

排除标准

  • 未提供

研究组 & 干预措施

cases of study

Patients is diabetes whether recently discovered or long standing diabetes

干预措施: Gliflozin (Drug)

controls of study

prediabetics ,or patients with clinical manifestations of insulin resistance eg acanthosis negricans

干预措施: Gliflozin (Drug)

结局指标

主要结局

prevention of diabetic complications

时间窗: 5 years

glomerular filtration rate will be measured at the beginning of the study and at the end

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Abdelkawi Hammad

Lecturer of internal medicine

Fayoum University

相似试验